GlassScriptPhysician profile
Amanda L Roeder
NPI 1003396821
$2,374.16
in general payments reported to CMS, 2019-2025
9 companies · $38.13 in 2025
The $38.13 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $45.05 · 2022: $109 · 2023: $2,150 · 2024: $32.47 · 2025: $38.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,385 · Travel and Lodging: $835.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,385.06 |
| Travel and Lodging | $835.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,645.45 | 2023 | Watchman Access System, Rezum Generator, Watchman Flx |
| Janssen Pharmaceuticals, INC | $236.64 | 2021-2023 | Xarelto |
| Abbott Laboratories | $218.44 | 2023 | Aveir, Jot Dx, Assurity |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $108.56 | 2022-2025 | Lifevest |
| Impulse Dynamics (USA) INC. | $71.08 | 2023 | Optimizer |
| Medtronic, INC. | $47.77 | 2021-2022 | |
| Pfizer INC. | $17.77 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $14.70 | 2021 | |
| Janssen Biotech, INC. | $13.75 | 2025 | Tremfya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Roeder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.